Nov 2015 $2 M No. 7 $2 to $10 million 18
Bioptix Diagnostics, Inc.: Raise no. 7, Nov 2015 × Investors in this round 18 investors had bought by the notice of May 13, 2016: 18 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $4 M offered; $2 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last more than a year
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Richard Whitcomb · Executive Officer, Director Dmitry Akhanov · Director J. William Freytag · Director John Creecy · Director Kyle Lefkoff · Director Michael Routh · Director Ron Lowy · Director William Marshall · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Richard Whitcomb, President and Chief Executive Officer. Source: SEC Form D and 2 amendments, newest notice filed May 13, 2016. Read the notice at the SEC .
equity SEC Feb 2015 $2 M No. 6 Under $2 million 2
Bioptix Diagnostics, Inc.: Raise no. 6, Feb 2015 × Investors in this round 2 investors had bought by the notice of Feb 26, 2015: 2 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $2 M offered; $1 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Richard Whitcomb · Executive Officer, Director Dmitry Akhanov · Director J. William Freytag · Director John Creecy · Director Kyle Lefkoff · Director Michael Routh · Director Ron Lowy · Director William Marshall · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Richard Whitcomb, President and CEO. Source: SEC Form D, newest notice filed Feb 26, 2015. Read the notice at the SEC .
equity, options SEC Jul 2014 $2 M No. 5 $2 to $10 million 18
Bioptix Diagnostics, Inc.: Raise no. 5, Jul 2014 × Investors in this round 18 investors had bought by the notice of Aug 13, 2014: 18 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $2 M offered; $0 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Richard Whitcomb · Executive Officer, Director Dmitry Akhanov · Director J. William Freytag · Director John Creecy · Director Kyle Lefkoff · Director Michael Routh · Director Ron Lowy · Director William Marshall · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Richard Whitcomb, President and CEO. Source: SEC Form D, newest notice filed Aug 13, 2014. Read the notice at the SEC .
equity, options SEC Feb 2013 $6 M No. 4 $2 to $10 million 25
Bioptix Diagnostics, Inc.: Raise no. 4, Feb 2013 × Investors in this round 25 investors had bought by the notice of Mar 13, 2013: 25 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $6 M of $8 M offered; $2 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Nolan Smith · Executive Officer Richard Whitcomb · Executive Officer, Director Dmitry Akhanov · Director J. William Freytag · Director John Creecy · Director Kyle Lefkoff · Director Michael Routh · Director Ron Lowy · Director William Marshall · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Richard Whitcomb, President and CEO. Source: SEC Form D, newest notice filed Mar 13, 2013. Read the notice at the SEC .
equity, options SEC Mar 2011 $4 M No. 3 $2 to $10 million 26
Bioptix Diagnostics, Inc.: Raise no. 3, Mar 2011 × Investors in this round 26 investors had bought by the notice of Mar 17, 2011: 26 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $4 M of $9 M offered; $5 M still to sell
Smallest investment taken $1
What was sold equity, other: Includes conversion of outstanding convertible promissory notes.
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Richard Whitcomb · Executive Officer, Director J. William Freytag · Director Kyle Lefkoff · Director Ron Lowy · Director William Marshall · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Richard Whitcomb, President. Source: SEC Form D, newest notice filed Mar 17, 2011. Read the notice at the SEC .
equity SEC Aug 2010 $1 M No. 2 Under $2 million 12
Bioptix Diagnostics, Inc.: Raise no. 2, Aug 2010 × Investors in this round 12 investors had bought by the notice of Aug 26, 2010: 12 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $1 M of $1 M offered; $0 M still to sell
Smallest investment taken $8,000
What was sold debt, options or other rights to buy securities, securities to be acquired by exercising them
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Richard Whitcomb · Executive Officer, Director J. William Freytag · Director Mikhail Plam · Director William Coleman · Director William Marshall · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Richard Whitcomb, President. Source: SEC Form D, newest notice filed Aug 26, 2010. Read the notice at the SEC .
debt, options SEC Mar 2009 $3 M No. 1 $2 to $10 million 14
Bioptix Diagnostics, Inc.: Raise no. 1, Mar 2009 × Investors in this round 14 investors had bought by the notice of Jul 13, 2009: 14 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $3 M of $3 M offered
Smallest investment taken $25,000
What was sold equity, options or other rights to buy securities
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Richard Whitcomb · Executive Officer, Director J. William Freytag · Director Mikhail Plam · Director William Coleman · Director William Marshall · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Includes conversion of principal and interest under outstanding promissory notes.”Signed by Richard Whitcomb, Ceo. Source: SEC Form D and 1 amendment, newest notice filed Jul 13, 2009. Read the notice at the SEC .
equity, options SEC